FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4248470337> ?p ?o ?g. }

• W4248470337 abstract "Hemophilia A and B are inherited coagulation disorders characterized by a reduced or absent level of factor VIII or factor IX respectively. The severe form is characterized by a factor level less than 0.01 international units (IU) per milliliter. The development of inhibitors in hemophilia is the main complication of treatment, because the presence of these antibodies, reduces or even nullifies the efficacy of replacement therapy, making it very difficult to control the bleeding. People with inhibitors continue to have significantly higher risks of morbidity and mortality, with considerable treatment costs. Given the wide 'off-label' use of rituximab for treating people with hemophilia and inhibitors, its efficacy and safety need to be evaluated. This is an update of a previously published Cochrane Review.To assess the efficacy and safety of rituximab for treating inhibitors in people with inherited severe hemophilia A or B.We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group's Coagulopathies Trials Register, complied from electronic database searches and handsearching of journals and conference abstract books. We searched the reference lists of relevant articles and reviews and also searched for ongoing or unpublished studies. We also undertook further searches of other bibliographic databases and trial registries. Date of last search of the Cochrane Cystic Fibrosis and Genetic Disorders Group's Coagulopathies Trials Register: 19 March 2020.Randomized controlled trials and controlled clinical trials investigating the efficacy and safety of rituximab for treating inhibitors in people with hemophilia.No randomized controlled trials matching the selection criteria were eligible for inclusion.No randomized controlled trials on rituximab for treating inhibitors in people with hemophilia were identified.We were unable to identify any relevant trials on the efficacy and safety of rituximab for treating inhibitors in people with hemophilia. The research evidence available is from case reports and case series. Randomized controlled trials are needed to evaluate the efficacy and safety of rituximab for this condition. However, prior to the publication of any possible future randomized controlled trials, meta-analysis of case reports and case series may provide some evidence." @default.
• W4248470337 created "2022-05-12" @default.
• W4248470337 creator A5001877165 @default.
• W4248470337 creator A5008659449 @default.
• W4248470337 creator A5021942877 @default.
• W4248470337 creator A5066768069 @default.
• W4248470337 creator A5073486623 @default.
• W4248470337 date "2020-08-03" @default.
• W4248470337 modified "2023-10-13" @default.
• W4248470337 title "Rituximab for treating inhibitors in people with inherited severe hemophilia" @default.
• W4248470337 cites W1525469616 @default.
• W4248470337 cites W1543992565 @default.
• W4248470337 cites W1566180036 @default.
• W4248470337 cites W183572008 @default.
• W4248470337 cites W1960888772 @default.
• W4248470337 cites W1963967196 @default.
• W4248470337 cites W1982158484 @default.
• W4248470337 cites W1991223023 @default.
• W4248470337 cites W2007490446 @default.
• W4248470337 cites W2016501369 @default.
• W4248470337 cites W2021873639 @default.
• W4248470337 cites W2025838690 @default.
• W4248470337 cites W2039215350 @default.
• W4248470337 cites W2049558499 @default.
• W4248470337 cites W2072864431 @default.
• W4248470337 cites W2103667265 @default.
• W4248470337 cites W2111622100 @default.
• W4248470337 cites W2118533061 @default.
• W4248470337 cites W2124275803 @default.
• W4248470337 cites W2130235475 @default.
• W4248470337 cites W2136353276 @default.
• W4248470337 cites W2146285888 @default.
• W4248470337 cites W2147887043 @default.
• W4248470337 cites W2149564822 @default.
• W4248470337 cites W2157823046 @default.
• W4248470337 cites W2163100333 @default.
• W4248470337 cites W2167864435 @default.
• W4248470337 cites W2250651564 @default.
• W4248470337 cites W2277843529 @default.
• W4248470337 cites W2317987431 @default.
• W4248470337 cites W2552415017 @default.
• W4248470337 cites W3190154328 @default.
• W4248470337 cites W4230230239 @default.
• W4248470337 cites W4231544757 @default.
• W4248470337 cites W4234858608 @default.
• W4248470337 cites W4240022684 @default.
• W4248470337 doi "https://doi.org/10.1002/14651858.cd010810.pub4" @default.
• W4248470337 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32761818" @default.
• W4248470337 hasPublicationYear "2020" @default.
• W4248470337 type Work @default.
• W4248470337 citedByCount "1" @default.
• W4248470337 countsByYear W42484703372021 @default.
• W4248470337 crossrefType "journal-article" @default.
• W4248470337 hasAuthorship W4248470337A5001877165 @default.
• W4248470337 hasAuthorship W4248470337A5008659449 @default.
• W4248470337 hasAuthorship W4248470337A5021942877 @default.
• W4248470337 hasAuthorship W4248470337A5066768069 @default.
• W4248470337 hasAuthorship W4248470337A5073486623 @default.
• W4248470337 hasBestOaLocation W42484703372 @default.
• W4248470337 hasConcept C126322002 @default.
• W4248470337 hasConcept C168563851 @default.
• W4248470337 hasConcept C187212893 @default.
• W4248470337 hasConcept C2779338263 @default.
• W4248470337 hasConcept C2780653079 @default.
• W4248470337 hasConcept C535046627 @default.
• W4248470337 hasConcept C71924100 @default.
• W4248470337 hasConcept C95190672 @default.
• W4248470337 hasConceptScore W4248470337C126322002 @default.
• W4248470337 hasConceptScore W4248470337C168563851 @default.
• W4248470337 hasConceptScore W4248470337C187212893 @default.
• W4248470337 hasConceptScore W4248470337C2779338263 @default.
• W4248470337 hasConceptScore W4248470337C2780653079 @default.
• W4248470337 hasConceptScore W4248470337C535046627 @default.
• W4248470337 hasConceptScore W4248470337C71924100 @default.
• W4248470337 hasConceptScore W4248470337C95190672 @default.
• W4248470337 hasIssue "8" @default.
• W4248470337 hasLocation W42484703371 @default.
• W4248470337 hasLocation W42484703372 @default.
• W4248470337 hasLocation W42484703373 @default.
• W4248470337 hasOpenAccess W4248470337 @default.
• W4248470337 hasPrimaryLocation W42484703371 @default.
• W4248470337 hasRelatedWork W1998212570 @default.
• W4248470337 hasRelatedWork W2052539084 @default.
• W4248470337 hasRelatedWork W2143803333 @default.
• W4248470337 hasRelatedWork W2507295142 @default.
• W4248470337 hasRelatedWork W2805808559 @default.
• W4248470337 hasRelatedWork W2972302572 @default.
• W4248470337 hasRelatedWork W3090452522 @default.
• W4248470337 hasRelatedWork W3159250744 @default.
• W4248470337 hasRelatedWork W4292236216 @default.
• W4248470337 hasRelatedWork W2903040050 @default.
• W4248470337 hasVolume "2020" @default.
• W4248470337 isParatext "false" @default.
• W4248470337 isRetracted "false" @default.
• W4248470337 workType "article" @default.